Pfizer says its COVID-19 vaccine protects kids as young as 12, shots could start by next school year
Pfizer says its COVID-19 vaccine protects kids as young as 12, shots could start by next school year

The findings of Pfizer's trial, released Wednesday, showed that the vaccine recorded 100% efficacy against the virus in 2,260 adolescents aged between 12 and 15.